Adam D. Levy

Chief Financial Officer

Chief Financial Officer at Acrivon Therapeutics, Inc., filing insider transactions on 2026-08-04.

Total Purchases

—

0 transactions

Total Sales

$2K

1 transaction

Companies Traded

1 total filings

Active Since

2026-08-04

Last: 2026-08-04

Companies

Acrivon Therapeutics, Inc.

Date	Ticker	Type	Shares	Price	Value	Owned After
2026-08-04	ACRV	Sale	1,142	$1.57	$2K	66.0K	SEC ↗